1,326 reports of this reaction
2.0% of all LISDEXAMFETAMINE DIMESYLATE reports
#10 most reported adverse reaction
DEPRESSION is the #10 most commonly reported adverse reaction for LISDEXAMFETAMINE DIMESYLATE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 1,326 FDA adverse event reports linking LISDEXAMFETAMINE DIMESYLATE to DEPRESSION. This represents approximately 2.0% of all 65,887 adverse event reports for this drug.
Patients taking LISDEXAMFETAMINE DIMESYLATE who experience depression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEPRESSION is a less commonly reported adverse event for LISDEXAMFETAMINE DIMESYLATE, but still significant enough to appear in the safety profile.
In addition to depression, the following adverse reactions have been reported for LISDEXAMFETAMINE DIMESYLATE:
The following drugs have also been linked to depression in FDA adverse event reports:
DEPRESSION has been reported as an adverse event in 1,326 FDA reports for LISDEXAMFETAMINE DIMESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEPRESSION accounts for approximately 2.0% of all adverse event reports for LISDEXAMFETAMINE DIMESYLATE, making it a notable side effect.
If you experience depression while taking LISDEXAMFETAMINE DIMESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.